Encompass Health Corporation
HealthcareNYSE:EHC · New York Stock Exchange
-$0.41 today
Vol 0.45M · Avg 0.92M
Balance Sheet
Inspect the capital base behind the business
Review assets, liabilities, equity, cash, and debt to judge whether the company has the financial position to support future returns.
Balance Sheet
Assets, liabilities & equity
| Cash & Equivalents | $163.4M |
| Short-term Investments | $37.1M |
| Receivables | $676.0M |
| Other Current | $152.6M |
| Total Current Assets | $1.0B |
| PP&E (Net) | $4.4B |
| Goodwill | $1.3B |
| Intangible Assets | $300.3M |
| Long-term Investments | $109.2M |
| Other Non-current | $135.2M |
| Total Non-current Assets | $6.3B |
| Total Assets | $7.3B |
Analysis
Selected assets total $7.3B for Latest. The largest visible component is PP&E (Net) at $4.4B, about 60.5% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.
Balance Sheet
Annual data · 5 periods
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $102.9M +20.5% | $85.4M -18.0% | $104.2M +378.0% | $21.8M -55.9% | $49.4M | $1.0B | $841.8M | $673.8M |
| Short-term Investments | $42.2M | $0 -100.0% | $37.6M | $0 | $0 | -$1.6B | $445.6M | $378.4M |
| Net Receivables | $619.2M +3.4% | $598.8M -2.1% | $611.6M +13.9% | $536.8M +6.9% | $502.1M | $533.8M | $399.4M | -$1.7B |
| Inventory | $0 | $0 | $0 | $0 | $0 | $641.6M | $328.0M | $316.8M |
| Other Current Assets | $87.7M -45.3% | $160.4M +197.6% | $53.9M -56.4% | $123.7M -51.5% | $255.0M | $1.5B | $966.4M | $764.8M |
| Total Current Assets | $905.9M +2.1% | $886.9M +5.4% | $841.8M +17.4% | $717.2M -22.2% | $921.4M | $12.5B | $10.5B | $5.5B |
| Property, Plant & Equipment (Net) | $4.3B +12.2% | $3.8B +9.6% | $3.5B +11.4% | $3.2B +13.6% | $2.8B | $1.2B | $1.5B | $687.8M |
| Goodwill | $1.3B +2.6% | $1.3B +0.2% | $1.3B +1.4% | $1.3B +2.1% | $1.2B | $925.8M | $466.6M | $309.8M |
| Intangible Assets | $308.3M +3.5% | $297.8M +7.0% | $278.2M -1.5% | $282.3M +78.2% | $158.4M | $568.8M | $860.0M | $1.5B |
| Long-term Investments | $129.1M +5.4% | $122.5M +11.9% | $109.5M | $0 | $0 | $524.0M | -$1.5B | $860.0M |
| Tax Assets | $0 | $0 | $0 | $0 | $0 | $1.5B | $1.4B | $1.4B |
| Other Non-current Assets | $114.6M +18.5% | $96.7M +17.8% | $82.1M -63.0% | $222.1M -87.5% | $1.8B | $1.4B | $1.0B | $679.4M |
| Total Non-current Assets | $6.2B +9.5% | $5.6B +7.4% | $5.3B +6.9% | $4.9B -17.2% | $5.9B | -$15.3B | $14.8B | $11.3B |
| Total Assets | $7.1B +8.5% | $6.5B +7.1% | $6.1B +8.3% | $5.6B -17.9% | $6.9B | $13.3B | $11.9B | $10.6B |
| Account Payables | $178.2M +4.2% | $171.0M +0.6% | $170.0M +27.9% | $132.9M -0.8% | $134.0M | $1.3B | -$1.5B | $1.4B |
| Short-term Debt | $70.1M -39.0% | $114.9M +135.0% | $48.9M +94.0% | $25.2M +34.8% | $18.7M | -$1.6B | -$1.6B | $326.6M |
| Tax Payables | $0 | $0 | $0 | $0 | $0 | $574.4M | -$1.5B | $1.4B |
| Deferred Revenue | $0 | $0 | $0 | $0 | $0 | -$1.6B | $374.2M | $542.2M |
| Other Current Liabilities | $588.1M +16.4% | $505.1M +119.6% | $230.0M +27.0% | $181.1M -31.4% | $264.1M | $1.1B | $1.5B | $493.2M |
| Total Current Liabilities | $836.4M -0.5% | $841.0M +28.1% | $656.4M +14.0% | $575.9M -23.1% | $748.8M | $6.0B | $10.1B | $14.3B |
| Long-term Debt | $2.2B +5.6% | $2.1B -12.9% | $2.4B -13.6% | $2.7B -3.8% | $2.9B | $1.3B | $438.6M | $1.3B |
| Deferred Tax Liabilities | $126.8M +20.5% | $105.2M +20.9% | $87.0M +4.8% | $83.0M | $0 | $746.6M | $612.2M | $477.8M |
| Deferred Revenue (Non-current) | $0 | $0 | $0 | $0 | $0 | -$1.6B | $715.8M | $1.3B |
| Other Non-current Liabilities | $206.9M +8.7% | $190.4M +7.0% | $177.9M +2.1% | $174.2M -41.3% | $296.8M | $489.0M | $1.1B | -$1.5B |
| Total Non-current Liabilities | $3.0B +4.7% | $2.8B -9.7% | $3.1B -1.6% | $3.2B -13.9% | $3.7B | $3.9B | $7.5B | $14.1B |
| Total Liabilities | $3.8B +3.5% | $3.7B -3.1% | $3.8B +0.8% | $3.8B -15.5% | $4.5B | $14.7B | $3.7B | $9.6B |
| Common Stock | $1.2M +0.0% | $1.2M +0.0% | $1.2M +9.1% | $1.1M +0.0% | $1.1M | $651.4M | $517.0M | $382.6M |
| Retained Earnings | $1.3B +61.8% | $796.7M +96.0% | $406.5M +251.3% | $115.7M -18.4% | $141.8M | -$1.6B | $519.8M | $1.1B |
| Accumulated OCI | $500.0K | $0 | $0 | $0 -100.0% | $0 | $393.8M | $550.6M | $707.4M |
| Other Stockholders Equity | $0 | $0 | $0 | $0 +100.0% | -$1 | $351.8M | -$1.6B | $1.5B |
| Minority Interest | $837.6M +7.1% | $782.2M +20.4% | $649.7M +17.8% | $551.6M +13.1% | $487.9M | $1.4B | $337.8M | $931.4M |
| Total Equity | $3.3B +15.0% | $2.8B +24.0% | $2.3B +23.4% | $1.9B -22.4% | $2.4B | $9.1B | $7.7B | $3.3B |
| Total Debt | $2.7B +0.0% | $2.7B -7.5% | $2.9B -2.0% | $3.0B -14.0% | $3.5B | $724.2M | $410.6M | $399.4M |
| Net Debt | $2.6B -0.7% | $2.6B -7.1% | $2.8B -4.8% | $3.0B -13.4% | $3.4B | $389.6M | $501.6M | $311.2M |
Older periods hidden.
Sign in to unlockCompetitors
Peer companies in the same sector
Solventum Corporation
NYSE:SOLV
$13.54B
DaVita Inc.
NYSE:DVA
$13.46B
Align Technology, Inc.
NASDAQ:ALGN
$12.50B
Fresenius Medical Care AG & Co. KGaA
NYSE:FMS
$12.37B
Elanco Animal Health Incorporated
NYSE:ELAN
$12.06B
ICON Public Limited Company
NASDAQ:ICLR
$11.19B
Dr. Reddy's Laboratories Limited
NYSE:RDY
$11.11B
Universal Health Services, Inc.
NYSE:UHS
$9.19B
The Ensign Group, Inc.
NASDAQ:ENSG
$8.68B
Chemed Corporation
NYSE:CHE
$5.58B
SEC Filings
Recent regulatory filings
No filings found.
How much cash does EHC have?
Encompass Health Corporation (EHC) reported $102.90M in cash and equivalents in fiscal 2025.
How much debt does EHC carry?
Encompass Health Corporation (EHC) reported $2.71B of total debt, with net debt of $2.61B.
Explore More
Continue the stock analysis
Jump to another research area for this company.